前列腺癌：对疾病进展和治疗挑战的见解
Prostate Cancer: Insights into Disease Progression and Therapeutic Challenges.
作者信息
Chakroborty Debanjan, Singh Ajay Pratap
机构信息
Department of Pathology, University of South Alabama, Mobile, AL 36617, USA.
Cancer Biology Program, Mitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
出版信息
Int J Mol Sci. 2024 Feb 20;25(5):2451. doi: 10.3390/ijms25052451.
Abstract
Prostate cancer (PCa) is the second most common cancer and the fifth highest cause of cancer-related death among men in the world [...].
摘要
前列腺癌（PCa）是全球男性中第二常见的癌症，也是癌症相关死亡的第五大原因[...]。
相似文献
1
Prostate Cancer: Insights into Disease Progression and Therapeutic Challenges.
Int J Mol Sci. 2024 Feb 20;25(5):2451. doi: 10.3390/ijms25052451.
2
The role of genetic markers in the management of prostate cancer.
Eur Urol. 2012 Oct;62(4):577-87. doi: 10.1016/j.eururo.2012.05.054. Epub 2012 Jun 5.
3
Associations between statin use and progression in men with prostate cancer treated with primary androgen deprivation therapy.
Scand J Urol. 2017 Dec;51(6):464-469. doi: 10.1080/21681805.2017.1362032. Epub 2017 Aug 23.
4
Role of lncRNAs in prostate cancer development and progression.
Biol Chem. 2014 Nov 1;395(11):1275-90. doi: 10.1515/hsz-2014-0201.
5
Identification of Differential Patterns of Oxidative Biomarkers in Prostate Cancer Progression.
Clin Genitourin Cancer. 2020 Apr;18(2):e174-e179. doi: 10.1016/j.clgc.2019.09.014. Epub 2019 Sep 26.
6
Special Issue: "Novel Researches and Perspectives on Prostate Cancer".
Int J Mol Sci. 2024 Feb 8;25(4):2054. doi: 10.3390/ijms25042054.
7
Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options.
J Immunol Res. 2020 May 25;2020:4910595. doi: 10.1155/2020/4910595. eCollection 2020.
8
Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.
BJU Int. 2012 Dec;110(11 Pt B):E541-6. doi: 10.1111/j.1464-410X.2012.11232.x. Epub 2012 May 15.
9
Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden.
BJU Int. 2023 Apr;131(4):486-493. doi: 10.1111/bju.15891. Epub 2022 Sep 26.
10
[Benign prostatic hypertrophy and prostate cancer].
Soins Gerontol. 2014 Sep-Oct(109):28-32.
引用本文的文献
1
Systemic immune-inflammation index is associated with high risk for prostate cancer among the U.S. elderly: Evidence from NHANES 2001-2010.
Front Oncol. 2024 Sep 23;14:1441271. doi: 10.3389/fonc.2024.1441271. eCollection 2024.
本文引用的文献
1
Cancer statistics, 2023.
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
2
The promising role of new molecular biomarkers in prostate cancer: from coding and non-coding genes to artificial intelligence approaches.
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):431-443. doi: 10.1038/s41391-022-00537-2. Epub 2022 Apr 14.
3
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
JAMA Netw Open. 2022 Jan 4;5(1):e2144027. doi: 10.1001/jamanetworkopen.2021.44027.
4
Metabolic reprogramming in prostate cancer.
Br J Cancer. 2021 Oct;125(9):1185-1196. doi: 10.1038/s41416-021-01435-5. Epub 2021 Jul 14.
5
Prostate cancer.
Nat Rev Dis Primers. 2021 Feb 4;7(1):9. doi: 10.1038/s41572-020-00243-0.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):290-300. doi: 10.1038/s41391-020-00296-y. Epub 2020 Oct 7.
8
Cardiovascular risks and toxicity - The Achilles heel of androgen deprivation therapy in prostate cancer patients.
Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188383. doi: 10.1016/j.bbcan.2020.188383. Epub 2020 Jun 11.
9
Sequential therapy of abiraterone and enzalutamide in castration-resistant prostate cancer: a systematic review and meta-analysis.
Prostate Cancer Prostatic Dis. 2020 Dec;23(4):539-548. doi: 10.1038/s41391-020-0222-6. Epub 2020 Mar 9.
10
Epidemiology of Prostate Cancer.
World J Oncol. 2019 Apr;10(2):63-89. doi: 10.14740/wjon1191. Epub 2019 Apr 20.
Zotero 插件